Answers are grounded in this paper and cite their sources.
Case series reveals heterogeneity of outcomes in pineal glioblastoma, highlighting the need for refined prognostication.
This represents the first pineal GBM cohort defined under 2021 WHO classification. Our findings highlight the heterogeneity of outcomes, underscoring the need for molecular and epigenetic stratification to refine prognostication and therapeutic decision-making.
No takes yet. Share an insight, caveat, or question.
Clerkin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: